These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9532519)

  • 1. Stepped care for hypertension: are the assumptions valid?
    Caro JJ
    J Hypertens Suppl; 1997 Dec; 15(7):S35-9. PubMed ID: 9532519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.
    Caro JJ; Speckman JL; Salas M; Raggio G; Jackson JD
    CMAJ; 1999 Jan; 160(1):41-6. PubMed ID: 9934342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
    Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term persistence with antihypertensive drugs in new patients.
    Degli Esposti E; Sturani A; Di Martino M; Falasca P; Novi MV; Baio G; Buda S; Volpe M
    J Hum Hypertens; 2002 Jun; 16(6):439-44. PubMed ID: 12037702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
    Bourgault C; Sénécal M; Brisson M; Marentette MA; Grégoire JP
    J Hum Hypertens; 2005 Aug; 19(8):607-13. PubMed ID: 15920457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario.
    Friedman O; McAlister FA; Yun L; Campbell NR; Tu K;
    Am J Med; 2010 Feb; 123(2):173-81. PubMed ID: 20103027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence with treatment for hypertension in actual practice.
    Caro JJ; Salas M; Speckman JL; Raggio G; Jackson JD
    CMAJ; 1999 Jan; 160(1):31-7. PubMed ID: 9934341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study.
    Erkens JA; Panneman MM; Klungel OH; van den Boom G; Prescott MF; Herings RM
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):795-803. PubMed ID: 16178043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary practice patterns in the management of newly diagnosed hypertension.
    McAlister FA; Teo KK; Lewanczuk RZ; Wells G; Montague TJ
    CMAJ; 1997 Jul; 157(1):23-30. PubMed ID: 9220938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existing treatment strategies: does noncompliance make a difference?
    Caro JJ; Speckman JL
    J Hypertens Suppl; 1998 Sep; 16(7):S31-4. PubMed ID: 9855029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of angiotensin II receptor blockers in the treatment of hypertension.
    Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive drug-associated sexual dysfunction: a prescription analysis-based study.
    al Khaja KA; Sequeira RP; al Damanhori AH; Mathur VS
    Pharmacoepidemiol Drug Saf; 2003; 12(3):203-12. PubMed ID: 12733473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence with hypertension treatment among community-dwelling BC seniors.
    Morgan SG; Yan L
    Can J Clin Pharmacol; 2004; 11(2):e267-73. PubMed ID: 15596883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
    Román O; Cuevas G; Bunout D
    Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.